New Jersey-based AACE Pharmaceuticals has been slammed in an FDA warning letter citing significant violations by its contract manufacturer Brassica Pharma, including substandard sanitary conditions ...
The U.S. Food and Drug Administration (FDA) sent over 50 warning letters to GLP-1 drug compounders and manufacturers in September 2025. The agency warned the companies that their statements that ...
Sprout Pharmaceuticals is once again under fire from the FDA’s Office of Prescription Drug Promotion (OPDP). The OPDP issued a warning letter to the drugmaker—dated May 29 and publicly released this ...
A seafood company failed to follow federal safety rules to prevent potential botulism contamination. A business was hawking dietary supplements with the misleading claim that they’d cure, treat or ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback